US FDA’s Pazdur On When And Why US Patients Must Satisfy Trial Diversity Requirements

 
• By Sarah Karlin-Smith
  
earth surrounded by lots of arms in different colors reaching toward it.
The FDA's Richard Pazdur offered advice on meeting diversity requirements with global trials during a 16 October meeting. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Diversity & Inclusion

More from R&D